1. Home
  2. CPSS vs TLSA Comparison

CPSS vs TLSA Comparison

Compare CPSS & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Consumer Portfolio Services Inc.

CPSS

Consumer Portfolio Services Inc.

HOLD

Current Price

$9.42

Market Cap

203.1M

Sector

Finance

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

SELL

Current Price

$1.49

Market Cap

200.8M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CPSS
TLSA
Founded
1991
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
203.1M
200.8M
IPO Year
1992
2000

Fundamental Metrics

Financial Performance
Metric
CPSS
TLSA
Price
$9.42
$1.49
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
20.4K
433.6K
Earning Date
11-10-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.80
N/A
Revenue
$196,531,000.00
N/A
Revenue This Year
$139.62
N/A
Revenue Next Year
$10.58
N/A
P/E Ratio
$11.89
N/A
Revenue Growth
6.67
N/A
52 Week Low
$6.67
$0.63
52 Week High
$12.73
$2.60

Technical Indicators

Market Signals
Indicator
CPSS
TLSA
Relative Strength Index (RSI) 68.21 36.01
Support Level $9.17 $1.39
Resistance Level $9.73 $1.60
Average True Range (ATR) 0.30 0.17
MACD 0.10 -0.02
Stochastic Oscillator 87.94 30.83

Price Performance

Historical Comparison
CPSS
TLSA

About CPSS Consumer Portfolio Services Inc.

Consumer Portfolio Services Inc is a U.S based company operating in the specialty finance sector. Its business is to purchase and service retail automobile contracts originated by franchised automobile dealers and, to a lesser extent by select independent dealers in the United States in the sale of new and used automobiles, light trucks, and passenger vans. Through its automobile contract purchases, the company provides indirect financing to the customers of dealers having limited credit histories, low incomes, or past credit problems, who it refers to as sub-prime customers. It serves as an alternative source of financing for dealers, facilitating sales to customers.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: